INTERLEUKIN-8 (IL-8), MELANOMA GROWTH-STIMULATORY ACTIVITY, AND NEUTROPHIL-ACTIVATING PEPTIDE SELECTIVELY MEDIATE PRIMING OF THE NEUTROPHILNADPH OXIDASE THROUGH THE TYPE-A OR TYPE-B IL-8 RECEPTOR
Sp. Green et al., INTERLEUKIN-8 (IL-8), MELANOMA GROWTH-STIMULATORY ACTIVITY, AND NEUTROPHIL-ACTIVATING PEPTIDE SELECTIVELY MEDIATE PRIMING OF THE NEUTROPHILNADPH OXIDASE THROUGH THE TYPE-A OR TYPE-B IL-8 RECEPTOR, The Journal of biological chemistry, 271(41), 1996, pp. 25400-25405
The capacity of neutrophils to generate superoxide (O-2(T)) can be enh
anced by prior exposure to ''priming'' agents such as interleukin-8 (I
L-8), melanoma growth-stimulatory activity (MGSA), and neutrophil-acti
vating peptide (ENA-78). The biological effects of these chemokines ar
e mediated by at least two distinct receptors: type A (IL-8-RA) and ty
pe B (IL-8-RB). Using neutralizing monoclonal antibodies to ILS-RA and
IL-8-RB, we have investigated the contribution each receptor makes to
the priming response, Preincubation with IL-8, MGSA, or ENA-78 enhanc
ed the ability of neutrophils to generate O-2(T) following stimulation
with the bacterial peptide formyl-Met-Leu-Phe. The priming effect of
IL-8 was eliminated by an anti-IL-8 monoclonal antibody (mAb) that is
known to bind IL-8 with high affinity and prevent receptor occupancy.
Incubation of neutrophils with a neutralizing mAb specific for IL-8-RA
blocked IL-8-induced priming but had no effect on priming by MGSA or
ENA-78. In contrast, treatment with a neutralizing mAb specific for IL
-8-RB faded to inhibit the priming effect of IL-8 but blocked both MGS
A and ENA-78-induced priming. These observations indicate that the pri
ming effect of IL-8 on the neutrophil respiratory burst is predominant
ly mediated via IL-8-RA whereas priming by MGSA and ENA-78 is mediated
by IL-8-RB.